中华微生物学和免疫学杂志
中華微生物學和免疫學雜誌
중화미생물학화면역학잡지
CHINESE JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY
2014年
5期
349-353
,共5页
渠利利%王彦云%龚来玲%沈鹏%朱进%司进
渠利利%王彥雲%龔來玲%瀋鵬%硃進%司進
거리리%왕언운%공래령%침붕%주진%사진
恶性疟原虫%环子孢子蛋白%肝细胞%靶向作用
噁性瘧原蟲%環子孢子蛋白%肝細胞%靶嚮作用
악성학원충%배자포자단백%간세포%파향작용
Plasmodium falciparum%Circumsporozoite protein%Hepatic cells%Targeting
目的:从恶性疟原虫FCC1/HN株环子孢子蛋白(circumsporozoite protein,CSP)的全长编码基因中扩增4个CSP基因编码片段,克隆至原核表达载体pET28 a/EGFP 中进行表达纯化,观察环子孢子蛋白肽段与EGFP融合蛋白对肝细胞的靶向结合能力,探讨其作为原发性肝癌基因治疗的靶向分子载体的可行性。方法根据恶性疟原虫FCC1/HN株环子孢子蛋白的编码序列设计4对引物,利用聚合酶链反应( PCR )扩增出4段CSP 的编码基因,将其克隆到原核表达载体pET28 a/EGFP中,与EGFP融合表达,在大肠杆菌BL21中用IPTG诱导表达,表达产物用Ni2+螯合柱亲和纯化,采用SDS-PAGE对纯化的融合蛋白检测;并观察重组环子孢子蛋白对不同组织细胞的结合能力。结果从恶性疟原虫FCC1/HN株CSP基因中成功扩增到4段分别为300、90、120、80 bp的基因片段,且在原核表达载体pET28 a/EGFP中经诱导表达出相对分子质量约39×103、31×103、33×103和30×103大小的融合蛋白: CSR1a-EGFP、CSR1b-EGFP、CSR2a-EGFP及CSR2b-EGFP;通过Ni2+亲和柱纯化获得重组CSP融合蛋白,能被疟原虫阳性血清特异识别,且CSR2 a-EGFP能够与肝癌和正常肝细胞特异性地结合,与其他组织来源的细胞则未见反应。结论重组环子孢子蛋白CSR2a-EGFP能够与肝组织特异性地结合,作为原发性肝癌基因治疗的靶向分子具有一定的潜在应用价值。
目的:從噁性瘧原蟲FCC1/HN株環子孢子蛋白(circumsporozoite protein,CSP)的全長編碼基因中擴增4箇CSP基因編碼片段,剋隆至原覈錶達載體pET28 a/EGFP 中進行錶達純化,觀察環子孢子蛋白肽段與EGFP融閤蛋白對肝細胞的靶嚮結閤能力,探討其作為原髮性肝癌基因治療的靶嚮分子載體的可行性。方法根據噁性瘧原蟲FCC1/HN株環子孢子蛋白的編碼序列設計4對引物,利用聚閤酶鏈反應( PCR )擴增齣4段CSP 的編碼基因,將其剋隆到原覈錶達載體pET28 a/EGFP中,與EGFP融閤錶達,在大腸桿菌BL21中用IPTG誘導錶達,錶達產物用Ni2+螯閤柱親和純化,採用SDS-PAGE對純化的融閤蛋白檢測;併觀察重組環子孢子蛋白對不同組織細胞的結閤能力。結果從噁性瘧原蟲FCC1/HN株CSP基因中成功擴增到4段分彆為300、90、120、80 bp的基因片段,且在原覈錶達載體pET28 a/EGFP中經誘導錶達齣相對分子質量約39×103、31×103、33×103和30×103大小的融閤蛋白: CSR1a-EGFP、CSR1b-EGFP、CSR2a-EGFP及CSR2b-EGFP;通過Ni2+親和柱純化穫得重組CSP融閤蛋白,能被瘧原蟲暘性血清特異識彆,且CSR2 a-EGFP能夠與肝癌和正常肝細胞特異性地結閤,與其他組織來源的細胞則未見反應。結論重組環子孢子蛋白CSR2a-EGFP能夠與肝組織特異性地結閤,作為原髮性肝癌基因治療的靶嚮分子具有一定的潛在應用價值。
목적:종악성학원충FCC1/HN주배자포자단백(circumsporozoite protein,CSP)적전장편마기인중확증4개CSP기인편마편단,극륭지원핵표체재체pET28 a/EGFP 중진행표체순화,관찰배자포자단백태단여EGFP융합단백대간세포적파향결합능력,탐토기작위원발성간암기인치료적파향분자재체적가행성。방법근거악성학원충FCC1/HN주배자포자단백적편마서렬설계4대인물,이용취합매련반응( PCR )확증출4단CSP 적편마기인,장기극륭도원핵표체재체pET28 a/EGFP중,여EGFP융합표체,재대장간균BL21중용IPTG유도표체,표체산물용Ni2+오합주친화순화,채용SDS-PAGE대순화적융합단백검측;병관찰중조배자포자단백대불동조직세포적결합능력。결과종악성학원충FCC1/HN주CSP기인중성공확증도4단분별위300、90、120、80 bp적기인편단,차재원핵표체재체pET28 a/EGFP중경유도표체출상대분자질량약39×103、31×103、33×103화30×103대소적융합단백: CSR1a-EGFP、CSR1b-EGFP、CSR2a-EGFP급CSR2b-EGFP;통과Ni2+친화주순화획득중조CSP융합단백,능피학원충양성혈청특이식별,차CSR2 a-EGFP능구여간암화정상간세포특이성지결합,여기타조직래원적세포칙미견반응。결론중조배자포자단백CSR2a-EGFP능구여간조직특이성지결합,작위원발성간암기인치료적파향분자구유일정적잠재응용개치。
Objective To amplify four fragments of circumsporozoite ( CSP) protein gene from Plasmodium falciparum FCC1/HN strain and express recombinant CSP proteins in prokaryotic vector pET28 a/EGFP for further evaluation of their binding activities to hepatic cells .Methods Four pairs of primers were designed according to the cDNA sequence of CSP protein from Plasmodium falciparum FCC1/HN strain and used to amplify the gene fragments by PCR .The cloned gene fragments were inserted into pET28a/EGFP to construct the recombinant expression plasmids .The transformed E.coli BL21 strains carry-ing expression plasmids were induced by IPTG to express CPS proteins .The recombinant CSP proteins were purified with Ni2+chelating HiTrap HP column and detected by SDS-PAGE.The binding activities of the ex-pressed proteins to different tissues were also detected .Results Four gene fragments encoding CSP protein were successfully amplified and expressed in E.coil BL21 strain as fusion protein CSR1a-EGFP, CSR1b-EGFP, CSR2a-EGFP and CSR2b-EGFP with a relative molecular mass of about 39×103, 31×103, 33×103 and 30 ×10 3 , respectively .The purified fusion proteins reacted specifically with Plasmodium falciparum-posi-tive serum samples.Moreover, the recombinant protein CSR2a-EGFP could bind to the hepatic cells specif-ically rather than other cells.Conclusion The purified recombinant CSR2a-EGFP protein has a strong binding activity to hepatocytes , indicating its potential value as a targeting molecule for hepatic gene therapy .